Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal calcitonin for postoperative pain after maxillofacial fracture surgery
IRCT20190409043211N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of TBRIA in facial fracture and Mandible fracture (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Apr 2019; status: completed.
02
Drugs
TBRIA
03
Conditions
facial fractureMandible fracture
Beyond the preview
Go deeper on IRCT20190409043211N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190409043211N1.